Cardiology Clinical Trials

Join Volt Atrial Fibrillation Clinical Trials in Oklahoma City to help advance innovative treatments for Persistent Atrial Fibrillation (AFib). Hightower is evaluating the Volt™ Pulsed Field Ablation (PFA) system, a new approach for treating symptomatic, recurrent, drug-resistant AFib. Participation is voluntary and free, with no insurance required. The trial monitors the safety and effectiveness of the Volt™ PFA system. AFib increases the risk of stroke, heart failure, and blood clots, and participants will receive comprehensive care throughout the study. To participate, complete the form, and a research team member will contact you to determine eligibility.

Do you suffer from Cardiovascular Diseases and have elevated levels of cholesterol?

Cardiovascular diseases and their complications are among the leading causes of death in the United States and worldwide. To help reduce the burden of heart disease, Hightower is conducting Clinical Research in Cardiology.

We are currently enrolling volunteers in a Phase 3 Clinical Trial on an investigational medication for Atherosclerotic Cardiovascular Disease.

This study aims to observe whether the study drug could reduce 4-Point-Major Adverse Cardiovascular Events, non-fatal myocardial infarction (MI), non-fatal ischemic stroke, and urgent coronary revascularization.

*All study procedures and study-related treatment, including the investigational drug, are free of cost, and insurance is not required to participate.*

Heart failure is a chronic condition affecting millions in the U.S., often leading to impaired kidney function. Hightower Clinical is conducting clinical trials in Oklahoma City to explore innovative treatments for heart failure and its impact on kidney health. By joining the trial, you can contribute to advancing treatment options and potentially improve your own quality of life. If you’re struggling with heart failure, this is your chance to help shape future therapies. All study-related procedures will be provided free of charge.

Severe hypertriglyceridemia can lead to serious health issues like pancreatitis and cardiovascular disease. Hightower Clinical is conducting clinical trials in Oklahoma City to test an investigational drug aimed at reducing triglyceride levels. Participation is voluntary, free, and open to individuals aged 22 and older. The trial involves being randomly placed into either a Control group (receiving a placebo) or an Experimental group (receiving the drug). With thorough care from experienced physicians, this study aims to find better treatments. Enroll today to see if you qualify and contribute to improving health outcomes.